docetaxel anhydrous has been researched along with glutathione disulfide in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (glutathione disulfide) | Trials (glutathione disulfide) | Recent Studies (post-2010) (glutathione disulfide) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 3,285 | 71 | 990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avisar, E; Deutsch, YE; Diaz-Montero, CM; Garret-Mayer, E; Glück, S; Hurley, J; Jorda, M; Koniaris, LG; Montero, AJ; Pegram, MD; Rumboldt, T; Schuhwerk, K; Seo, P; Silva, O; Slingerland, J; Welsh, C; Yasir, S | 1 |
1 trial(s) available for docetaxel anhydrous and glutathione disulfide
| Article | Year |
|---|---|
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Combinations; Female; Glutathione Disulfide; Humans; Immunity, Cellular; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Receptor, ErbB-2; Taxoids; Treatment Outcome; Young Adult | 2012 |